Unexplained weight loss (UWL) is a diagnostic challenge in clinical practice. It is a potential indicator of serious underlying disease, often signaling malignancy, gastrointestinal disorders, or endocrine abnormalities. A systematic and comprehensive approach is essential to identify the cause and initiate appropriate management.
The initial evaluation of UWL should involve a detailed history and thorough physical examination. Clinicians should inquire about changes in appetite, dietary intake, and physical activity. History of associated symptoms, medication use, and psychosocial factors should also be considered. Physical examination can provide clues to systemic diseases such as malignancies or chronic infections.
Initial laboratory investigations should include complete blood count, comprehensive metabolic panel, thyroid function tests, and inflammatory markers. Imaging studies, such as chest radiographs and abdominal ultrasound, may be helpful based on the patient's symptoms and risk factors. Further diagnostic tests should be guided by initial findings and clinical suspicion.
In elderly patients, UWL may be the only manifestation of a serious disease. Therefore, a high index of suspicion is required. In patients with psychiatric history, disorders such as depression and eating disorders should be considered. In cases where no clear cause is identified despite extensive evaluation, a diagnosis of idiopathic UWL may be considered, and close follow-up is recommended.
Unexplained weight loss is a common but challenging clinical scenario. It requires a systematic and comprehensive approach to evaluation, including detailed history, physical examination, and judicious use of laboratory and imaging studies. Special considerations are needed for elderly patients and those with psychiatric history. Clinicians should maintain a high index of suspicion for serious underlying diseases and ensure close follow-up for patients with idiopathic UWL.
1.
Chemo-Free Triplet Yields 68% Response Rate in Richter Transformation
2.
Can Fasting Around Chemo Improve Ovarian Cancer Outcomes?
3.
Chemo causes lasting physical decline in breast cancer survivors
4.
MRI-guided radiation therapy improves quality of life with fewer side effects in patients with localized cancer. JAMA
5.
BMI is linked to heart damage from chemotherapy in breast cancer patients.
1.
The Role of the Oncology Pharmacist: From Treatment to Trials and Beyond
2.
Rehabilitation Following Bone Marrow Functional Suppression: Clinical Strategies and Advances
3.
Unlocking the Potential of Cancer Antigen 19-9 for Early Detection
4.
Strategic Breakthroughs in Oncology in Clinical Decision-Making
5.
Targeted Approaches to Breast Cancer Liver Metastases: Surgery, Ablation, and Survival Insights
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
2.
Early warning sings of camcer that need medical attention
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
4.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
5.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation